EMIL D KAKKIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EMIL D KAKKIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EMIL D KAKKIS. EMIL D KAKKIS is Chief Medical Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN).
Latest Insider Trading Transactions of EMIL D KAKKIS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.45 | 4,500 | 146,025 | 127,304 | 131.8 K to 127.3 K (-3.41 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.45 | 1,100 | 35,698 | 131,804 | 132.9 K to 131.8 K (-0.83 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.46 | 2,000 | 64,920 | 132,904 | 134.9 K to 132.9 K (-1.48 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.45 | 300 | 9,735 | 134,904 | 135.2 K to 134.9 K (-0.22 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.34 | 100 | 3,234 | 135,204 | 135.3 K to 135.2 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.44 | 200 | 6,488 | 135,304 | 135.5 K to 135.3 K (-0.15 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.43 | 200 | 6,486 | 135,504 | 135.7 K to 135.5 K (-0.15 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.46 | 400 | 12,982 | 135,704 | 136.1 K to 135.7 K (-0.29 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.46 | 100 | 3,246 | 136,104 | 136.2 K to 136.1 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.51 | 100 | 3,251 | 136,204 | 136.3 K to 136.2 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.47 | 300 | 9,741 | 136,304 | 136.6 K to 136.3 K (-0.22 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.42 | 100 | 3,242 | 136,604 | 136.7 K to 136.6 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.49 | 100 | 3,249 | 136,704 | 136.8 K to 136.7 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.50 | 5,300 | 172,250 | 136,804 | 142.1 K to 136.8 K (-3.73 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.51 | 1,000 | 32,510 | 142,104 | 143.1 K to 142.1 K (-0.70 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.51 | 1,900 | 61,775 | 143,104 | 145 K to 143.1 K (-1.31 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.53 | 100 | 3,253 | 145,004 | 145.1 K to 145 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.48 | 100 | 3,248 | 145,104 | 145.2 K to 145.1 K (-0.07 %) |
| Aug 05 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 32.47 | 100 | 3,247 | 145,204 | 145.3 K to 145.2 K (-0.07 %) |
Page: 1